STANDARD BIOTOOLS INC. — Director's Dealing 2020

May 23, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2020-05-20

Reporting Person: Linthwaite Stephen Christopher (President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-20	Common Stock	M	4750	—	Acquired	201343	Direct
2020-05-20	Common Stock	M	7812	—	Acquired	209155	Direct
2020-05-20	Common Stock	M	6882	—	Acquired	216037	Direct
2020-05-20	Common Stock	F	9791	$4.385	Disposed	206246	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-20	Restricted Stock Units	$	M	4750	Disposed		Common Stock (4750.0)	Direct
2020-05-20	Restricted Stock Units	$	M	7812	Disposed		Common Stock (7812.0)	Direct
2020-05-20	Restricted Stock Units	$	M	6882	Disposed		Common Stock (6882.0)	Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter.

F3: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter.

F4: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.